Dave Portnoy, president of Barstool Sports, slammed the NFL legend, Tom Brady, on X over his decision to clone his dog.

Last Thursday brought the shock announcement that Novo Nordisk had made a fresh play to buy the biotech, despite Pfizer ...

Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and profits thanks to an important cancer drug. It's developing other products ...

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...

US stocks (^DJI, ^GSPC, ^IXIC) bounce back on Wednesday after Tuesday's sell-off. Clough Capital CEO and president Vince Lorusso joins Market Catalysts with Yahoo Finance Senior Reporter Allie Canal, ...

Alt5 Sigma suspended Peter Tassiopoulos just two months after the company announced a $1.5 billion deal involving the ...

Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...

Despite the emphasis on detachment from ideas, X employees do have significant skin in the game when projects spin out.

Fortrea Holdings Inc. ( FTRE) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST ...

Guidelines have been established regarding the definition, diagnosis, and management of persistent chemotherapy-induced alopecia.

With all the AI bubble headlines out there, it’s easy to conclude that the great bull run will end in tears and perhaps ...